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Systemic lupus erythematosus (SLE) is a multifactorial
autoimmune disease in which environmental exposures
like virus infection and UV-irradiation trigger activa-
tion of the innate and adaptive immune system in
genetically predisposed individuals. Heterozygous
mutations of the 3’ repair exonuclease 1 (TREX1) are
associated with SLE. Biallelic mutations in TREX1 and
the three subunits of ribonuclease H2 (RNASEH2A-C)
cause Aicardi-Goutières syndrome, an inflammatory
encephalopathy with clinical overlap with SLE. We
therefore investigated the role of RNase H2 in SLE
pathogenesis. RNase H2 is responsible for the removal
of misincorporated ribonucleotides from DNA and is
indispensable for genome integrity. We demonstrated a
genetic association for rare RNase H2 sequence var-
iants with SLE. RNase H2-deficient fibroblasts of AGS
and SLE patients accumulated ribonucleotides in geno-
mic DNA resulting in chronic low-level DNA damage,
constitutive p53 phosphorylation and senescence.
Patient fibroblasts proliferated slower than fibroblasts
from healthy individuals and showed impairment of
cell cycle progression. In addition, patient fibroblasts
exhibited constitutive up-regulation of interferon-
stimulated genes and an enhanced type I interferon
response to the nucleic acid poly(I:C) and UV-irradia-
tion. UV-irradiation induced enhanced cyclobutane
pyrimidine dimer formation in ribonucleotide-containing
DNA. This suggests that innate immune activation may be
caused by immune recognition of DNA metabolites of
DNA damage repair and may also explain photosensitivity
in SLE patients with RNase H2 mutation. In summary,
our findings implicate RNase H2 in the pathogenesis
of SLE, and suggest a role of DNA damage-associated
pathways in the initiation of autoimmunity.
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